ElendiLabs
Stage C applies to all medical devices procured by the DH, including Class II, III, and IV general medical devices and Class B, C, and D in vitro diagnostic medical devices.
Post your regulatory questions or request quotations from verified pharmaceutical consultants worldwide. Get matched with experts who specialize in your market.
April 12, 2025
Approximately 5 minutes
From what we've seen, Hong Kong's medical market is full of great opportunities for companies making medical devices. To successfully bring and sell medical devices here, you absolutely need to follow the rules. While Hong Kong's main system, the Medical Device Administrative Control System (MDACS), is currently a voluntary program for listing devices, we know from experience that it's a super important step for getting your products into the market and preparing for stricter rules that might come later.
Specialized consulting services are available to help medical device companies efficiently navigate the regulatory hurdles in Hong Kong and gain timely access to its medical market.
When we talk about "medical devices" in Hong Kong, what exactly does the Department of Health's Medical Device Division (MDD) consider to be one? According to their guidelines, a medical device is essentially any instrument, apparatus, machine, appliance, implant, software, material, or similar item. It's important that the manufacturer intends it to be used, either alone or with other things, for specific medical purposes in humans.
These purposes include:
Crucially, a medical device does not achieve its main effect in or on the body through drugs, immune responses, or metabolism. However, it might be helped in its function by such means. So, it's pretty broad, covering everything from a simple bandage to complex diagnostic software!
From our experience, simplifying the registration process is key. That's why we focus on getting medical devices ready for MDACS listing, making the whole journey smoother and helping products get through complex rules much faster. Key aspects of such services include:
From what we've observed, Hong Kong is really appealing for medical device companies because of a few key reasons:
By using specialized expertise, companies can meet Hong Kong's rules efficiently and truly get their medical devices into the market. From our experience, these services help you understand everything from how devices are classified to what documents you need, and even how to keep an eye on your product once it's out there for long-term success in Hong Kong. Are you considering bringing a new medical device to Hong Kong, and wondering which step to tackle first?
We'll follow up with you personally.
ElendiLabs
Stage C applies to all medical devices procured by the DH, including Class II, III, and IV general medical devices and Class B, C, and D in vitro diagnostic medical devices.
Anonymous
We want to use an independent third-party Local Responsible Person (LRP) to maintain control over our technical files. However, our local distributor claims that if they are not the LRP, they cannot be listed as the 'Authorized Importer' in the Hospital Authority’s procurement system. Is it possible to separate the Regulatory Listing (LRP) from the Commercial Importer status in the MDIS portal?
ElendiLabs
Absolutely. The MDACS explicitly separates these roles. The LRP is the legal representative to the Department of Health (DH) for safety and vigilance. The Listed Importer (of which there can be many) is a commercial role. You can appoint an independent LRP to "own" the listing and then authorize multiple distributors as "Listed Importers" under your listing. This ensures that if you change distributors, you do not lose your HKMD Listing Number or have to re-register from scratch
Anonymous
The Centre for Medical Products Regulation (CMPR) is expected to be fully operational by the end of 2026. If we list our devices under the current 'voluntary' MDACS system now, will our listing be automatically 'grandfathered' into the mandatory statutory registration once the new law is passed, or will we have to pay new fees and undergo a fresh 'Primary Evaluation'?
ElendiLabs
Current policy indicates a seamless transition. Devices with a valid MDACS Listing Number when the new legislation is enacted will be automatically transitioned into the mandatory register. They will retain their existing HKMD numbers but will be subject to the new, stricter Post-Market Surveillance (PMS) and Vigilance reporting requirements of the CMPR. Companies that wait for the mandatory system to launch will likely face higher fees and a more rigorous "Primary Evaluation" instead of the current "Leveraged Approval" pathway.
Approximately 5 minutes
Adverse event reporting is a critical component of Hong Kong's Medical Device Administrative Control System (MDACS), aiming to enhance public health and safety. This article outlines the requirements and responsibilities of Local Responsible Persons (LRPs) in reporting adverse events related to listed medical devices, based on our insights.
Approximately 5 minutes
Complete guide to medical device regulations, classification, registration requirements and post-market surveillance in Hong Kong.
Approximately 5 minutes
Hong Kong's Medical Device Administrative Control System (MDACS) provides a robust, although currently voluntary, framework for regulating medical devices. This article explores the system's key features, including device classification, the listing process, the crucial role of Local Responsible Persons (LRPs), and its increasing importance for market access and public procurement, all from our insights and experience.
Approximately 5 minutes
This article details the application process for local medical device manufacturers seeking to be listed under Hong Kong's Medical Device Administrative Control System (MDACS), as guided by GN-08. It covers eligibility, quality management system requirements, and the submission process, all based on our insights and experience for effective Hong Kong medical device manufacturing.
Approximately 5 minutes
For entities importing medical devices into Hong Kong, the Medical Device Administrative Control System (MDACS) provides a voluntary listing scheme for importers, guided by GN-07. This article details the eligibility, application steps, and key requirements for listing as a medical device importer, based on our insights and experience for efficient Hong Kong medical device import.
Approximately 5 minutes
This article outlines the application process for medical device distributors seeking to be listed under Hong Kong's Medical Device Administrative Control System (MDACS), as detailed in GN-09. It covers eligibility, key requirements for documented procedures, and the submission process to enhance traceability and public safety, based on our insights.
Approximately 5 minutes
This article details the application process for listing Class B, C, and D In Vitro Diagnostic Medical Devices (IVDMDs) under Hong Kong's Medical Device Administrative Control System (MDACS), as guided by GN-06. It covers classification, eligibility, submission requirements, and the online application via MDIS, all based on our insights and experience for efficient IVDMD listing in Hong Kong.
Anonymous
Does Stage C apply to Class II medical devices for home-use? Or does this only apply to hospital products that are procured by the DH?